Explaining B. Cepacia in Cystic Fibrosis Patients

Wendy Henderson avatar

by Wendy Henderson |

Share this article:

Share article via email

https://www.youtube.com/watch?v=cibUxH6qUio

In this Cystic Fibrosis Foundation webcast, burkholderia cepacia complex, more commonly known as B. cepacia is explained and the effect it has on patients with cystic fibrosis.

A study finds that chronic lung infections in CF patients are worsened by viruses. Find out more.

Dr. John LiPuma from the University of Michigan shares that B. cepacia is a bacteria that affects the lungs of cystic fibrosis patients. LiPuma also explains that B. cepacia affects each cystic fibrosis patient differently, with some having more severe lung-function decline than others. He goes on to explain how the infection is caught and what patients can do to avoid coming into contact with the bacteria.

Breakthrough therapy for resistant lung infection in cystic fibrosis revealed at European CF conference. Find out more.

 

Cystic Fibrosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.